Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Jul 29, 2026
- Incorporated
- Delaware
- Filings on record
- 641 filings
- On EDGAR
- CIK 1607678
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 46
News 8 of 107
- 8-K Quarterly results Jul 29, 2026
- 8-K Shareholder vote results May 26, 2026
- 8-K Quarterly results Apr 29, 2026
- 8-K Quarterly results Feb 11, 2026
- 8-K Quarterly results Oct 22, 2025
- 8-K Current report on a material event Aug 19, 2025
- 8-K Quarterly results Jul 23, 2025
- 8-K Shareholder vote results May 27, 2025
Prospectuses and Registrations 8 of 69
- S-3ASR Automatic shelf registration Jul 30, 2026
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration May 23, 2024
Proxies 8 of 26
- DEFA14A Extra proxy material Apr 1, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEFR14A Apr 23, 2025
- DEFA14A Extra proxy material Apr 8, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
Ownership 8 of 325
- 4 Insider reported a trade Aug 7, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 29, 2026
Other 8 of 68
- ARS Annual report sent to shareholders Apr 1, 2026
- UPLOAD Comment letter from SEC staff Apr 21, 2025
- CORRESP Reply to SEC staff Apr 8, 2025
- ARS Annual report sent to shareholders Apr 8, 2025
- UPLOAD Comment letter from SEC staff Mar 31, 2025
- ARS Annual report sent to shareholders Apr 5, 2024
- ARS Annual report sent to shareholders May 1, 2023
- EFFECT Notice that a registration became effective Aug 11, 2021
Everything here comes from Viking Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.